Back

SGLT2 inhibitors: evidence across the spectrum of heart failure.

26 August 2022 (14:36 - 14:54)
Organised by:
Congress Presentation Part of: Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail
The spectrum of heart failure: current concepts in defining systolic and diastolic cardiac dysfunction.
Professor C. Ceconi (Desenzano Del Garda, IT)
Slides Video
Presentation thumbnail
ARNI: evidence across the spectrum of heart failure.
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
Putting it all together: ARNI, SGLT2 inhibitors and other drugs across the spectrum of heart failure.
Doctor E. O'Meara (Montreal, CA)
Slides Video

Access the full session

Session thumbnail
Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 14:36 CET
You may be interested in
thumbnail
Congress Session
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Webinar
SGLT2 inhibitors across the left ventricular function spectrum

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources